Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2001 Nov;60(Suppl 3):iii43–iii46. doi: 10.1136/ard.60.90003.iii43

Role of cytokines in the innate immune response to intracellular pathogens

S Stenger, M Rollinghoff
PMCID: PMC1766676  PMID: 11890652

Full Text

The Full Text of this article is available as a PDF (159.0 KB).

Figure 1  .

Figure 1  

Open in a new tab

Toll-like receptors and host defence.    

graphic file with name ard-agem.f1.jpg

Open in a new tab

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assreuy J., Cunha F. Q., Epperlein M., Noronha-Dutra A., O'Donnell C. A., Liew F. Y., Moncada S. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur J Immunol. 1994 Mar;24(3):672–676. doi: 10.1002/eji.1830240328. [DOI] [PubMed] [Google Scholar]
  2. Barral A., Barral-Netto M., Yong E. C., Brownell C. E., Twardzik D. R., Reed S. G. Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3442–3446. doi: 10.1073/pnas.90.8.3442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Belardelli F., Gresser I. The neglected role of type I interferon in the T-cell response: implications for its clinical use. Immunol Today. 1996 Aug;17(8):369–372. doi: 10.1016/0167-5699(96)10027-X. [DOI] [PubMed] [Google Scholar]
  4. Bogdan C., Donhauser N., Döring R., Röllinghoff M., Diefenbach A., Rittig M. G. Fibroblasts as host cells in latent leishmaniosis. J Exp Med. 2000 Jun 19;191(12):2121–2130. doi: 10.1084/jem.191.12.2121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bogdan C., Röllinghoff M. How do protozoan parasites survive inside macrophages? Parasitol Today. 1999 Jan;15(1):22–28. doi: 10.1016/s0169-4758(98)01362-3. [DOI] [PubMed] [Google Scholar]
  6. Bogdan C. The function of type I interferons in antimicrobial immunity. Curr Opin Immunol. 2000 Aug;12(4):419–424. doi: 10.1016/s0952-7915(00)00111-4. [DOI] [PubMed] [Google Scholar]
  7. Cisneros J. R., Murray K. M. Corticosteroids in tuberculosis. Ann Pharmacother. 1996 Nov;30(11):1298–1303. doi: 10.1177/106002809603001115. [DOI] [PubMed] [Google Scholar]
  8. Daley C. L., Small P. M., Schecter G. F., Schoolnik G. K., McAdam R. A., Jacobs W. R., Jr, Hopewell P. C. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med. 1992 Jan 23;326(4):231–235. doi: 10.1056/NEJM199201233260404. [DOI] [PubMed] [Google Scholar]
  9. De Libero G., Flesch I., Kaufmann S. H. Mycobacteria-reactive Lyt-2+ T cell lines. Eur J Immunol. 1988 Jan;18(1):59–66. doi: 10.1002/eji.1830180110. [DOI] [PubMed] [Google Scholar]
  10. Di Perri G., Cruciani M., Danzi M. C., Luzzati R., De Checchi G., Malena M., Pizzighella S., Mazzi R., Solbiati M., Concia E. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet. 1989 Dec 23;2(8678-8679):1502–1504. [PubMed] [Google Scholar]
  11. Diefenbach A., Schindler H., Donhauser N., Lorenz E., Laskay T., MacMicking J., Röllinghoff M., Gresser I., Bogdan C. Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity. 1998 Jan;8(1):77–87. doi: 10.1016/s1074-7613(00)80460-4. [DOI] [PubMed] [Google Scholar]
  12. Diefenbach A., Schindler H., Röllinghoff M., Yokoyama W. M., Bogdan C. Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. Science. 1999 May 7;284(5416):951–955. doi: 10.1126/science.284.5416.951. [DOI] [PubMed] [Google Scholar]
  13. Ding A. H., Nathan C. F., Stuehr D. J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol. 1988 Oct 1;141(7):2407–2412. [PubMed] [Google Scholar]
  14. Evans T. G., Thai L., Granger D. L., Hibbs J. B., Jr Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J Immunol. 1993 Jul 15;151(2):907–915. [PubMed] [Google Scholar]
  15. Flynn J. L., Ernst J. D. Immune responses in tuberculosis. Curr Opin Immunol. 2000 Aug;12(4):432–436. doi: 10.1016/s0952-7915(00)00116-3. [DOI] [PubMed] [Google Scholar]
  16. Kaufmann S. H. CD8+ T lymphocytes in intracellular microbial infections. Immunol Today. 1988 Jun;9(6):168–174. doi: 10.1016/0167-5699(88)91292-3. [DOI] [PubMed] [Google Scholar]
  17. Kirschning C. J., Wesche H., Merrill Ayres T., Rothe M. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med. 1998 Dec 7;188(11):2091–2097. doi: 10.1084/jem.188.11.2091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Laskay T., Röllinghoff M., Solbach W. Natural killer cells participate in the early defense against Leishmania major infection in mice. Eur J Immunol. 1993 Sep;23(9):2237–2241. doi: 10.1002/eji.1830230928. [DOI] [PubMed] [Google Scholar]
  19. Liew F. Y., Li Y., Millott S. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol. 1990 Dec 15;145(12):4306–4310. [PubMed] [Google Scholar]
  20. Liew F. Y., Millott S., Parkinson C., Palmer R. M., Moncada S. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J Immunol. 1990 Jun 15;144(12):4794–4797. [PubMed] [Google Scholar]
  21. Louis J., Himmelrich H., Parra-Lopez C., Tacchini-Cottier F., Launois P. Regulation of protective immunity against Leishmania major in mice. Curr Opin Immunol. 1998 Aug;10(4):459–464. doi: 10.1016/s0952-7915(98)80121-0. [DOI] [PubMed] [Google Scholar]
  22. Mattner J., Schindler H., Diefenbach A., Röllinghoff M., Gresser I., Bogdan C. Regulation of type 2 nitric oxide synthase by type 1 interferons in macrophages infected with Leishmania major. Eur J Immunol. 2000 Aug;30(8):2257–2267. doi: 10.1002/1521-4141(2000)30:8<2257::AID-IMMU2257>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
  23. Medzhitov R., Preston-Hurlburt P., Janeway C. A., Jr A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997 Jul 24;388(6640):394–397. doi: 10.1038/41131. [DOI] [PubMed] [Google Scholar]
  24. Poltorak A., He X., Smirnova I., Liu M. Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998 Dec 11;282(5396):2085–2088. doi: 10.1126/science.282.5396.2085. [DOI] [PubMed] [Google Scholar]
  25. Proudfoot L., Nikolaev A. V., Feng G. J., Wei W. Q., Ferguson M. A., Brimacombe J. S., Liew F. Y. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10984–10989. doi: 10.1073/pnas.93.20.10984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Scharton T. M., Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med. 1993 Aug 1;178(2):567–577. doi: 10.1084/jem.178.2.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Solbach W., Laskay T. The host response to Leishmania infection. Adv Immunol. 2000;74:275–317. doi: 10.1016/s0065-2776(08)60912-8. [DOI] [PubMed] [Google Scholar]
  28. Stead W. W., Dutt A. K. Tuberculosis in the elderly. Semin Respir Infect. 1989 Sep;4(3):189–197. [PubMed] [Google Scholar]
  29. Stenger S., Donhauser N., Thüring H., Röllinghoff M., Bogdan C. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med. 1996 Apr 1;183(4):1501–1514. doi: 10.1084/jem.183.4.1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Stenger S., Hanson D. A., Teitelbaum R., Dewan P., Niazi K. R., Froelich C. J., Ganz T., Thoma-Uszynski S., Melián A., Bogdan C. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science. 1998 Oct 2;282(5386):121–125. doi: 10.1126/science.282.5386.121. [DOI] [PubMed] [Google Scholar]
  31. Stenger S., Mazzaccaro R. J., Uyemura K., Cho S., Barnes P. F., Rosat J. P., Sette A., Brenner M. B., Porcelli S. A., Bloom B. R. Differential effects of cytolytic T cell subsets on intracellular infection. Science. 1997 Jun 13;276(5319):1684–1687. doi: 10.1126/science.276.5319.1684. [DOI] [PubMed] [Google Scholar]
  32. Stenger S., Modlin R. L. T cell mediated immunity to Mycobacterium tuberculosis. Curr Opin Microbiol. 1999 Feb;2(1):89–93. doi: 10.1016/s1369-5274(99)80015-0. [DOI] [PubMed] [Google Scholar]
  33. Stenger S., Thüring H., Röllinghoff M., Bogdan C. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J Exp Med. 1994 Sep 1;180(3):783–793. doi: 10.1084/jem.180.3.783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Thoma-Uszynski S., Stenger S., Takeuchi O., Ochoa M. T., Engele M., Sieling P. A., Barnes P. F., Rollinghoff M., Bolcskei P. L., Wagner M. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science. 2001 Feb 23;291(5508):1544–1547. doi: 10.1126/science.291.5508.1544. [DOI] [PubMed] [Google Scholar]
  35. Wang Z. E., Reiner S. L., Zheng S., Dalton D. K., Locksley R. M. CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J Exp Med. 1994 Apr 1;179(4):1367–1371. doi: 10.1084/jem.179.4.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wei X. Q., Charles I. G., Smith A., Ure J., Feng G. J., Huang F. P., Xu D., Muller W., Moncada S., Liew F. Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 1995 Jun 1;375(6530):408–411. doi: 10.1038/375408a0. [DOI] [PubMed] [Google Scholar]
  37. Yang R. B., Mark M. R., Gray A., Huang A., Xie M. H., Zhang M., Goddard A., Wood W. I., Gurney A. L., Godowski P. J. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature. 1998 Sep 17;395(6699):284–288. doi: 10.1038/26239. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES